A multicenter retrospective study of charcot‐marie‐tooth disease type 4B (CMT4B) associated with mutations in myotubularin‐related proteins (MTMRs)
暂无分享,去创建一个
A. Mégarbané | L. Santoro | Y. Parman | A. Quattrone | R. Horvath | D. Herrmann | N. Lévy | S. Scherer | E. Battaloğlu | A. Geroldi | D. Pareyson | A. Schenone | C. Gemelli | C. Bacon | M. Shy | M. Reilly | P. Latour | T. Stojkovic | Byung-Ok Choi | S. Léonard-Louis | I. Tramacere | S. Magri | S. Previtali | A. Bolino | S. Sacconi | T. Murakami | P. Valentino | M. Sabatelli | F. Manganelli | M. Luigetti | M. Laurá | G. Solé | C. Pisciotta | A. Zambon | M. Tazir | J. Blake | R. Guimarães-Costa | G. Ricci | Lois Dankwa | S. Attarian | N. Bonello-Palot | Mounia Bellatache | S. Leonard-Louis | Chelsea J. Bacon | Tatsufumi Murakami
[1] Wanjin Chen,et al. Clinical and genetic investigation in Chinese patients with demyelinating Charcot‐Marie‐Tooth disease , 2018, Journal of the peripheral nervous system : JPNS.
[2] O. Birk,et al. Novel SBF1 splice‐site null mutation broadens the clinical spectrum of Charcot‐Marie‐Tooth type 4B3 disease , 2018, Clinical genetics.
[3] B. Schlotter-Weigel,et al. Novel SBF2 mutations and clinical spectrum of Charcot‐Marie‐Tooth neuropathy type 4B2 , 2018, Clinical genetics.
[4] F. Fares,et al. Whole-Exome Sequencing Identifies a Novel Homozygous Frameshift Mutation in the MTMR2 Gene as a Causative Mutation in a Patient with Charcot-Marie-Tooth Disease Type 4B1 , 2018, Molecular Neurobiology.
[5] I. Katona,et al. Frequent genes in rare diseases: panel‐based next generation sequencing to disclose causal mutations in hereditary neuropathies , 2017, Journal of neurochemistry.
[6] N. Romero,et al. P.251 Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy , 2017, Neuromuscular Disorders.
[7] G. Comi,et al. Vocal cord paralysis in Charcot–Marie–Tooth type 4b1 disease associated with a novel mutation in the myotubularin-related protein 2 gene: A case report and review of the literature , 2017, Neuromuscular Disorders.
[8] C. Brombin,et al. Niacin‐mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination , 2016, EMBO molecular medicine.
[9] M. Reilly,et al. Recent advances in the genetic neuropathies. , 2016, Current opinion in neurology.
[10] Z. Bruwer,et al. Occurrence of Optic Neuritis and Cervical Cord Schwannoma with Charcot-Marie-Tooth Type 4B1 Disease. , 2016, Oman medical journal.
[11] Tommaso Mazza,et al. “Fork and bracket” syndrome expands the spectrum of SBF1-related sensory motor polyneuropathies , 2016, Neurology: Genetics.
[12] L. Gutmann,et al. Update on Charcot-Marie-Tooth disease. , 2015, Current opinion in neurology.
[13] A. Kiger,et al. Starvation‐induced MTMR13 and RAB21 activity regulates VAMP8 to promote autophagosome–lysosome fusion , 2015, EMBO reports.
[14] L. Negrão,et al. Charcot-Marie-Tooth 4B2 caused by a novel mutation in the MTMR13/SBF2 gene in two related Portuguese families , 2014, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[15] Yanhua Chen,et al. Identification of A Novel SBF2 Frameshift Mutation in Charcot–Marie–Tooth Disease Type 4B2 Using Whole-exome Sequencing , 2014, Genom. Proteom. Bioinform..
[16] D. Pareyson,et al. Charcot-Marie-Tooth Disease and Related Hereditary Neuropathies: From Gene Function to Associated Phenotypes. , 2014, Current molecular medicine.
[17] Saeed Bohlega,et al. SET binding factor 1 (SBF1) mutation causes Charcot-Marie-Tooth disease type 4B3 , 2014, Neurology.
[18] Y. Sunada,et al. Mild phenotype of Charcot–Marie–Tooth disease type 4B1 , 2013, Journal of the Neurological Sciences.
[19] J. Polke,et al. Clinical implications of genetic advances in Charcot–Marie–Tooth disease , 2013, Nature Reviews Neurology.
[20] Jeffrey A. Porter,et al. PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling. , 2013, Chemistry & biology.
[21] A. Bolino,et al. A novel homozygous mutation in the MTMR2 gene in two siblings with ‘hypermyelinating neuropathy’ , 2013, Journal of the peripheral nervous system : JPNS.
[22] Kyoko Watanabe,et al. Molecular analysis of the genes causing recessive demyelinating Charcot–Marie–Tooth disease in Japan , 2013, Journal of Human Genetics.
[23] Salwa Hindawi,et al. Identification of a novel SBF2 missense mutation associated with a rare case of thrombocytopenia using whole-exome sequencing , 2013, Journal of Thrombosis and Thrombolysis.
[24] D. Benbrook,et al. Integration of autophagy, proteasomal degradation, unfolded protein response and apoptosis. , 2012, Experimental oncology.
[25] A. Kiger,et al. Sbf/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodeling , 2012, Molecular biology of the cell.
[26] A. Bolino,et al. Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. , 2012, Trends in molecular medicine.
[27] R. Finkel,et al. Validation of the Charcot–Marie–Tooth disease pediatric scale as an outcome measure of disability , 2012, Annals of neurology.
[28] M. Meisler,et al. Genetic Interaction between MTMR2 and FIG4 Phospholipid Phosphatases Involved in Charcot-Marie-Tooth Neuropathies , 2011, PLoS genetics.
[29] M. Mcdermott,et al. Reliability of the CMT neuropathy score (second version) in Charcot‐Marie‐Tooth disease , 2011, Journal of the peripheral nervous system : JPNS.
[30] B. Ceulemans,et al. Genetic spectrum of hereditary neuropathies with onset in the first year of life , 2011, Brain : a journal of neurology.
[31] N. Lévy,et al. Novel mutations in the PRX and the MTMR2 genes are responsible for unusual Charcot-Marie-Tooth disease phenotypes , 2011, Neuromuscular Disorders.
[32] F. Muntoni,et al. 168th ENMC International Workshop: Outcome measures and clinical trials in Charcot–Marie–Tooth disease (CMT) , 2010, Neuromuscular Disorders.
[33] Diana Rodriguez,et al. Multiple cranial nerve neuropathies, microcephaly, neurological degeneration, and “fork and bracket sign” in the MRI: A distinct syndrome , 2010, American journal of medical genetics. Part A.
[34] Kihoon Han,et al. The Phosphoinositide 3-Phosphatase MTMR2 Interacts with PSD-95 and Maintains Excitatory Synapses by Modulating Endosomal Traffic , 2010, The Journal of Neuroscience.
[35] A. Chishti,et al. Dlg1, Sec8, and Mtmr2 Regulate Membrane Homeostasis in Schwann Cell Myelination , 2009, The Journal of Neuroscience.
[36] Davide Pareyson,et al. Diagnosis, natural history, and management of Charcot–Marie–Tooth disease , 2009, The Lancet Neurology.
[37] M. Waterfield,et al. A selective PIKfyve inhibitor blocks PtdIns(3,5)P2 production and disrupts endomembrane transport and retroviral budding , 2008, EMBO reports.
[38] A. Quattrini,et al. Charcot–Marie–Tooth type 4B demyelinating neuropathy: deciphering the role of MTMR phosphatases , 2007, Expert Reviews in Molecular Medicine.
[39] Klaus-Armin Nave,et al. Axonal regulation of myelination by neuregulin 1 , 2006, Current Opinion in Neurobiology.
[40] U. Suter,et al. Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2. , 2006, Human molecular genetics.
[41] J. Dixon,et al. The Phosphoinositide-3-phosphatase MTMR2 Associates with MTMR13, a Membrane-associated Pseudophosphatase Also Mutated in Type 4B Charcot-Marie-Tooth Disease* , 2005, Journal of Biological Chemistry.
[42] P. Brophy,et al. Clinicopathological and genetic study of early-onset demyelinating neuropathy. , 2004, Brain : a journal of neurology.
[43] E. Génin,et al. Coincidence of two genetic forms of Charcot–Marie–Tooth disease in a single family , 2004, Neurology.
[44] A. Quattrone,et al. A new SBF2 mutation in a family with recessive demyelinating Charcot-Marie-Tooth (CMT4B2) , 2004, Neurology.
[45] M Nakagawa,et al. SET binding factor 2 (SBF2) mutation causes CMT4B with juvenile onset glaucoma , 2004, Neurology.
[46] N. Ban,et al. Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. Ravazzolo,et al. Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. , 2003, American journal of human genetics.
[48] J. Dixon,et al. Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[49] K. Zerres,et al. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. , 2003, Human molecular genetics.
[50] C. Broeckhoven,et al. A novel homozygous missense mutation in the myotubularin-related protein 2 gene associated with recessive Charcot–Marie–Tooth disease with irregularly folded myelin sheaths , 2002, Neuromuscular Disorders.
[51] U. Suter,et al. Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. , 2002, Human molecular genetics.
[52] P K Thomas,et al. Mutations in the 5' region of the myotubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. , 2001, Brain : a journal of neurology.
[53] A. Monaco,et al. Denaturing high-performance liquid chromatography of the myotubularin-related 2 gene (MTMR2) in unrelated patients with Charcot-Marie-Tooth disease suggests a low frequency of mutation in inherited neuropathy , 2001, Neurogenetics.
[54] Aldo Quattrone,et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2 , 2000, Nature Genetics.
[55] M. Devoto,et al. Genetic heterogeneity in autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths (CMT4B) , 1998, Neurology.
[56] C. Broeckhoven,et al. Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic, and genetic aspects of a large family. , 1996, Neurology.
[57] E. Bertini,et al. Autosomal recessive hypermyelinating neuropathy , 1994, Acta Neuropathologica.
[58] S. Friant,et al. WANTED - Dead or alive: Myotubularins, a large disease-associated protein family. , 2017, Advances in biological regulation.
[59] M. Reilly,et al. SBF1 mutations associated with autosomal recessive axonal neuropathy with cranial nerve involvement , 2016, neurogenetics.